State of Wisconsin Investment Board’s Genomic Health, Inc. GHDX Stock Holding History

State of Wisconsin Investment Board’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-95,300	Closed	-$6.46M	–	1656
2019 Q3	$6.46M	Buy	95,300 +64,900	+213%	+$4.46M	0.02%	762
2019 Q2	$1.77M	Buy	30,400 +2,300	+8%	+$136K	﹤0.01%	1038
2019 Q1	$1.97M	Buy	28,100 +6,400	+29%	+$475K	0.01%	1014
2018 Q4	$1.4M	Buy	21,700 +600	+3%	+$42.1K	﹤0.01%	1044
2018 Q3	$1.48M	Hold	21,100	–	–	﹤0.01%	1100
2018 Q2	$1.06M	Buy	21,100 +6,100	+41%	+$242K	﹤0.01%	1153
2018 Q1	$469K	Hold	15,000	–	–	﹤0.01%	1315
2017 Q4	$513K	Hold	15,000	–	–	﹤0.01%	1290
2017 Q3	$481K	Hold	15,000	–	–	﹤0.01%	1303
2017 Q2	$488K	Buy	+15,000	New	+$475K	﹤0.01%	1287

State of Wisconsin Investment Board's GHDX Position: Q4 2019 in Review

State of Wisconsin Investment Board sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 95,300 shares — an estimated $6.46M sold.

State of Wisconsin Investment Board first reported a position in GHDX in Q2 2017 and held it in 10 quarters. The position peaked at $6.46M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

State of Wisconsin Investment Board reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
State of Wisconsin Investment Board sold 95,300 Genomic Health, Inc. shares in Q4 2019, an estimated $6.46M.
State of Wisconsin Investment Board first reported a position in Genomic Health, Inc. in Q2 2017 and held it in 10 quarters.
State of Wisconsin Investment Board's Genomic Health, Inc. position peaked at $6.46M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2019, filed 14 Feb 2020.